COMMUNIQUÉS West-GlobeNewswire

BlossomHill Therapeutics Expands Board of Directors with the Appointments of Sheila Gujrathi, M.D., and John Schmid
20/05/2026
Seasoned biopharmaceutical leaders bring significant clinical development, financial and strategic expertise to support BlossomHill's next phase of growth SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- BlossomHill [...]
New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization
20/05/2026
Compared to patients adherent to monthly injectable buprenorphine, patients on other MOUD (adherent and non-adherent) were 3.5 to 8.1x more likely to return to opioid use. In a separate study, patients receiving monthly [...]
Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform
20/05/2026
ANN ARBOR, Mich., May 20, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced additional [...]
Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update
20/05/2026
Initiated a rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tinlarebant for the treatment of Stargardt disease type 1 (STGD1); submission expected to be completed in [...]
Avricore Health Announces $1.25 Million Financing
20/05/2026
VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ Avricore ”) announces a non-brokered private placement of up to 25,000,000 units ("Units") at a price [...]
Largest-ever Canadian clinical trial tests “poop pills” to improve immunotherapy for lung cancer
20/05/2026
Backed by the Canadian Cancer Society and Weston Family Foundation, the LUNA-2 microbiome capsule research study will be the largest of its kind in Canada LONDON, Ontario, May 20, 2026 (GLOBE NEWSWIRE) -- For nearly [...]
Un essai clinique canadien sans précédent évalue des « comprimés de selles » pour améliorer l’immunothérapie du cancer du poumon
20/05/2026
Financée par la Société canadienne du cancer et la Fondation de la famille Weston, l’étude de recherche LUNA-2 sur les capsules de microbiome sera la plus vaste du genre au Canada LONDON, Ontario, 20 mai 2026 (GLOBE [...]
CorVel Announces Revenues and Earnings
20/05/2026
FORT WORTH, Texas, May 20, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter and fiscal year ended March 31, 2026. Revenues for the fiscal year ended March 31, 2026 were $ [...]
Disclosure of voting rights at AGM in Vistin Pharma ASA
20/05/2026
Oslo, Norway, 20 May 2026 In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on the 20th of May, the Company's Chair of the Board, Øyvin Brøymer, has received open proxies to represent a total [...]
Winner Medical Breaks Ground on New Production Base in Vietnam to Serve Global Medical Supply Chains Through Local Manufacturing
20/05/2026
SHENZHEN, China, May 20, 2026 (GLOBE NEWSWIRE) -- Winner Medical has officially broken ground on its new manufacturing base in Hai Ha Industrial Park, Quang Ha Commune, Quang Ninh Province, Vietnam. With a total [...]
Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders
20/05/2026
Urges Stockholders to Vote “ FOR ” the Election of Pacira’s Highly Qualified Nominees on the BLUE Proxy Card Today BRISBANE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the “Company [...]
IBA launches Rhodotron® LITE, a new low‑power X‑ray accelerator expanding access to sustainable irradiation solutions
20/05/2026
Louvain-la-Neuve, Belgium, May 20, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial advanced irradiation, [...]
Synendos Therapeutics Starts Phase 2 Trial in Generalized Anxiety Disorder
20/05/2026
Collaboration underway with Prof. Allan Young and King’s College, London First time a Selective Endocannabinoid Reuptake Inhibitor (SERI) molecule is dosed in a patient population BASEL, Switzerland, May 20, 2026 (GLOBE [...]
SERB Pharmaceuticals acquiert auprès de Hansa Biopharma les droits européens et MENA d’Idefirix® (imlifidase) pour 115 millions d’euros
20/05/2026
BRUXELLES, 20 mai 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, ci-après « SERB », et Hansa Biopharma AB, ci-après « Hansa » (Nasdaq Stockholm : HNSA) annoncent la conclusion d’un accord portant sur l’acquisition, par [...]
IBA lance Rhodotron® LITE, un nouvel accélérateur à rayons X de faible puissance qui facilite l’accès à des solutions d’irradiation durables
20/05/2026
Louvain-la-Neuve, Belgique, le 20 mai 2026 – IBA (Ion Beam Applications S.A., EURONEXT), leader mondial des technologies d’accélérateurs de particules et des solutions de faisceaux d’électrons et à rayons X pour l’ [...]
SlimTide Claims Evaluated: The Baking Soda Water Shot Gelatin Trick for Losing Weight Naturally by Slim Tide
20/05/2026
Chicory Root Inulin, Resistant Starch, and Akkermansia Muciniphila Probiotic Blend for Gut Microbiome and Metabolic Support Explained Largo, FL, May 19, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated [...]
Shiny Smile Veneers Claims Evaluated (2026 Consumer Report Update) Critical Complaints Investigated
20/05/2026
Dr. Dean's Dentist-Designed Custom Snap-On Veneers: At-Home Impressions, FDA-Approved Biocompatible Resin, 3-Year Warranty, and 60-Day Money-Back Guarantee Richardson, TX , May 19, 2026 (GLOBE NEWSWIRE) -- Results may [...]
Java Tide Critical Assessment: The Gelatin Ice Trick Before Bed Using the Java Tide Formula Recipe
20/05/2026
Java Tide Scam or Legit, Complaints, Side Effects, and Supplement Ingredients: Chicory Root Inulin, Resistant Starch, Akkermansia muciniphila, and Gut Support Largo, FL, May 19, 2026 (GLOBE NEWSWIRE) -- These statements [...]
Ipsen annonce des données « late-breaking » issues de la première étude comparative directe entre Dysport® et Botox® chez des adultes atteints de spasticité du membre supérieur
19/05/2026
Essai de phase IV comparatif direct, en double aveugle, évaluant la tolérance et l’efficacité ayant atteint ses critères principaux et secondaires Les résultats de l’étude DIRECTION montrent que le profil de sécurité de [...]

Pages